Stockscreener 앱 받기
64.00
0.62%
-0.40
시간 외 거래:
63.95
-0.05
-0.08%
Utah Medical Products Inc 주식(UTMD)의 최신 뉴스
Sentiment Review: What is the implied volatility of Utah Medical Products Inc2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn
Trend Review: Will Utah Medical Products Inc benefit from sector rotation2026 Support & Resistance & Verified Technical Trade Signals - baoquankhu1.vn
Utah Medical Products Adjusts Valuation Amid Mixed Financial Performance and Strong Returns - Markets Mojo
Utah Medical Products (NASDAQ:UTMD) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
DelveInsight Business Research, LLP: Global Electrosurgical Devices Market Witnessing Strong Expansion at a CAGR of ~6% by 2034, Driven by Advanced Surgical Energy Technologies | DelveInsight - FinanzNachrichten.de
Global Electrosurgical Devices Market Witnessing Strong Expansion at a CAGR of ~6% by 2034, Driven by Advanced Surgical Energy Technologies | DelveInsight - Yahoo Finance Singapore
EPA moves to weaken pollution limits on chemical used to sterilize medical equipment - ABC4 Utah
Assessing Merit Medical Systems (MMSI) Valuation After Recent Share Price Weakness - simplywall.st
Utah Medical Products Inc Stock Historical Valuations - GuruFocus
Utah Medical Products Inc Stock Warning Signs | STU:UTM - GuruFocus
Medical ring-removal device invented by Nova Scotians gets a supporting role in HBO Max's The Pitt - PNI Atlantic News
Utah Medical Products Inc Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint
Mountain Lake Lodge Announces New Executive Leadership and Key Team Promotions - Weekly Voice
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire UK
Utah Medical Products (FRA:UTM) NonCurrent Deferred Revenue : €0.00 Mil (As of Sep. 2025) - GuruFocus
UTMD (Utah Medical Products) NonCurrent Deferred Revenue : $0.00 Mil (As of Sep. 2025) - GuruFocus
UTMD SEC FilingsUtah Med Prods 10-K, 10-Q, 8-K Forms - Stock Titan
(UTMD) Risk Channels and Responsive Allocation - Stock Traders Daily
Quarterly Earnings: Can Utah Medical Products Inc stock outperform in a bear marketSwing Trade & Daily Profit Maximizing Tips - baoquankhu1.vn
Can Utah Medical Products Inc sustain its profitabilityQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Biomedical Gas Analyzers Market Size to Reach 3,500 USD Million by 2035, Growing at 5.4% CAGR - industrytoday.co.uk
Aug Movers: Can Utah Medical Products Inc outperform under higher oil prices2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Analysis Recap: Is Utah Medical Products Inc stock undervalued right now2025 Bull vs Bear & Weekly High Potential Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Utah Medical Products (STU:UTM) 5-Year Dividend Growth Rate : 2.60% (As of Sep. 2025) - GuruFocus
Earnings Recap: Why is Utah Medical Products Inc stock going down2025 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Utah Medical Products (STU:UTM) Altman Z-Score : 40.23 (As of Feb. 28, 2026) - GuruFocus
UTMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
(UTMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight - openPR.com
UTMD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Retail Trends: Is now the right time to enter RZLV2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Utah Medical Products Inc (STU:UTM) Valuation: Modestly Overvalued - GuruFocus
Utah Medical Products (STU:UTM) Other Stockholders Equity : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Treasury Stock : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Retained Earnings : €109.02 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Utah Medical Products (STU:UTM) Capital Expenditure : €-0.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Cash, Cash Equivalents, Mar - GuruFocus
Utah Medical Products (STU:UTM) Shareholder Yield % : 8.45% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Median PS Value - GuruFocus
Utah Medical Products (STU:UTM) FCF Yield % : 6.53 (As of Feb. 25, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Equity : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Other : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Long-Term Capital Lease Obl - GuruFocus
Utah Medical Products (STU:UTM) Minority Interest : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Operating Income : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 10-Year ROIIC % : 2.08% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) YoY Rev. per Sh. Growth : 0.50% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Accounts Payable & Accrued Expense : €2.57 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Goodwill : €11.97 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Machinery, Furniture, Equipment : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) ROIC % : 23.16% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Short-Term Debt : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 3-Year ROIIC % : 22.67% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) Sale Of Property, Plant, Eq - GuruFocus
Utah Medical Products (STU:UTM) EPS (Basic) : €3.05 (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Interest Coverage : N/A (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) EV-to-OCF : 8.64 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Common Stock : €0.03 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Net Income From Continuing Operations : €10.35 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Competitors 2026 - GuruFocus
Utah Medical Products (STU:UTM) EBIT : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Payments to Suppliers for G - GuruFocus
Utah Medical Products (STU:UTM) Non Operating Income : €1.51 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Total Operating Expense : €9.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Current Assets : €0.36 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Asset : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Finished Goods : €1.04 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Net Income (Loss) : €-0.46 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Construction In Progress : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Price-to-Tangible-Book : 2.07 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (NASDAQ:UTMD) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Is Utah Medical Products Inc. stock a buy or sellJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Liquidity Mapping Around (UTMD) Price Events - Stock Traders Daily
Utah Medical's Q4 earnings hurt by OEM decline, fall y/y - MSN
0.06%
0.65%
자본화:
|
볼륨(24시간):